Related Experiment Video
Updated: Mar 31, 2026

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.8K
Acute Stroke: Shifting From Informed Consent to Informed Refusal of Intravenous Tissue-Type Plasminogen Activator
1From the Department of Neurology, MGH Stroke Services, Fireman Vascular Center, Massachusetts General Hospital, Harvard Medical School, Boston. Lschwamm@partners.org.
Circulation. Cardiovascular Quality and Outcomes
|October 31, 2015
Abstract
No abstract available in PubMed .

